Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T85025 | Target Info | |||
Target Name | Interleukin 7 receptor alpha (IL7R) | ||||
Synonyms | Interleukin-7 receptor subunit alpha; IL-7RA; IL-7R-alpha; IL-7R subunit alpha; IL-7R alpha chain; IL-7 receptor subunit alpha; CDw127; CD127 antigen; CD127 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | IL7R | ||||
Biochemical Class | Cytokine receptor | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | alpha-L-Fucose | Ligand Info | |||
Canonical SMILES | CC1C(C(C(C(O1)O)O)O)O | ||||
InChI | 1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3+,4+,5-,6+/m0/s1 | ||||
InChIKey | SHZGCJCMOBCMKK-SXUWKVJYSA-N | ||||
PubChem Compound ID | 439554 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 3UP1 Crystal structure of the unliganded human interleukin-7 receptor extracellular domain | ||||||
Method | X-ray diffraction | Resolution | 2.15 Å | Mutation | Yes | [1] |
PDB Sequence |
DAELDDYSFS
21 CYSQLEVNGS31 QHSLTCAFED41 PDVNTTNLEF51 EICGALVEVK61 CLNFRKLQEI 71 YFIETKKFLL81 IGKSNICVKV91 GEKSLTCKKI101 DLTTIVKPEA111 PFDLSVVYRE 121 GANDFVVTFN131 TSHLQKKYVK141 VLMHDVAYRQ151 EKDENKWTHV161 NLSSTKLTLL 171 QRKLQPAAMY181 EIKVRSIPDH191 YFKGFWSEWS201 PSYYFRTPEI211 N |
|||||
|
||||||
PDB ID: 6P67 Crystal Structure of a Complex of human IL-7Ralpha with an anti-IL-7Ralpha 2B8 Fab | ||||||
Method | X-ray diffraction | Resolution | 2.90 Å | Mutation | No | [2] |
PDB Sequence |
DYSFSCYSQL
26 EVNGSQHSLT36 CAFEDPDVNT46 TNLEFEICGA56 LVEVKCLNFR66 KLQEIYFIET 76 KKFLLIGKSN86 ICVKVGEKSL96 TCKKIDLTTI106 VKPEAPFDLS116 VVYREGANDF 126 VVTFNTSHLQ136 KKYVKVLMHD146 VAYRQEKDEN156 KWTHVNLSST166 KLTLLQRKLQ 176 PAAMYEIKVR186 SIPDHYFKGF196 WSEWSPSYYF206 RTPEI
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structural reorganization of the interleukin-7 signaling complex. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2503-8. | ||||
REF 2 | New anti-IL-7RAlpha monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models. Leukemia. 2020 Jan;34(1):35-49. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.